Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.53
-0.01 (-0.18%)
At close: Dec 5, 2025, 4:00 PM EST
5.52
-0.01 (-0.18%)
After-hours: Dec 5, 2025, 6:29 PM EST
Compass Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | 0.85 | - | - | - | - | |
| Gross Profit | - | 0.85 | - | - | - | - | |
| Selling, General & Admin | 16.09 | 15.13 | 12.24 | 11.66 | 10.93 | 12.91 | |
| Research & Development | 55.34 | 42.34 | 38.12 | 30 | 20.34 | 14.9 | |
| Operating Expenses | 71.42 | 57.48 | 50.36 | 41.66 | 31.26 | 27.81 | |
| Operating Income | -71.42 | -56.63 | -50.36 | -41.66 | -31.26 | -27.81 | |
| Interest Expense | - | - | - | - | -0.37 | -0.91 | |
| Interest & Investment Income | 5.62 | 7.25 | 7.87 | 2.36 | 0.03 | 0.09 | |
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0 | |
| Other Non Operating Income (Expenses) | - | - | - | - | - | -0.56 | |
| EBT Excluding Unusual Items | -65.81 | -49.38 | -42.49 | -39.3 | -31.61 | -29.19 | |
| Gain (Loss) on Sale of Assets | - | - | - | 0.07 | 0.04 | -0.28 | |
| Pretax Income | -65.81 | -49.38 | -42.49 | -39.23 | -82.18 | -29.47 | |
| Income Tax Expense | - | - | - | - | - | 0.03 | |
| Net Income | -65.81 | -49.38 | -42.49 | -39.23 | -82.18 | -29.5 | |
| Net Income to Common | -65.81 | -49.38 | -42.49 | -39.23 | -82.18 | -29.5 | |
| Shares Outstanding (Basic) | 146 | 137 | 127 | 105 | 63 | 31 | |
| Shares Outstanding (Diluted) | 146 | 137 | 127 | 105 | 63 | 31 | |
| Shares Change (YoY) | 8.16% | 8.15% | 20.76% | 67.31% | 104.28% | 359.96% | |
| EPS (Basic) | -0.45 | -0.36 | -0.33 | -0.37 | -1.31 | -0.96 | |
| EPS (Diluted) | -0.45 | -0.36 | -0.33 | -0.37 | -1.31 | -0.96 | |
| Free Cash Flow | -45.08 | -44.9 | -40.65 | -34.34 | -21.55 | -26.91 | |
| Free Cash Flow Per Share | -0.31 | -0.33 | -0.32 | -0.33 | -0.34 | -0.87 | |
| Gross Margin | - | 100.00% | - | - | - | - | |
| Operating Margin | - | -6661.76% | - | - | - | - | |
| Profit Margin | - | -5808.82% | - | - | - | - | |
| Free Cash Flow Margin | - | -5282.23% | - | - | - | - | |
| EBITDA | -71.02 | -56.04 | -49.66 | -40.87 | -30.7 | -25.41 | |
| D&A For EBITDA | 0.4 | 0.59 | 0.7 | 0.78 | 0.57 | 2.4 | |
| EBIT | -71.42 | -56.63 | -50.36 | -41.66 | -31.26 | -27.81 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.